PhillyPharma Archive: September, 2012

Public disclosure to the SEC? Sure. How about a jury?

Comment icon 0 Comments
A plaintiff suing Johnson & Johnson over the side effects of the antipsychotic drug Risperdal and allegations that the company promoted... Read more

'Risperdal Popcorn' – part of Day 2 of Philly trial

Comment icon 0 Comments
Johnson & Johnson increased sales of the antipsychotic drug Risperdal by paying doctors to speak about the drug, paying for their golf... Read more

Tuesday night TV: Money & Medicine

Comment icon 0 Comments
We usually leave TV previews to the professionals elsewhere in the Inquirer, but if you care about health care and the costs and have control... Read more

Philly judge stops J&J attempt to bar Inquirer reporter from courtroom

Comment icon 0 Comments
A Philadelphia judge thwarted an attempt by Johnson & Johnson attorneys to prevent an Inquirer reporter from entering a courtroom during... Read more

Philly judge: J&J's Alex Gorsky does not have to testify

Comment icon 0 Comments
A Philadelphia judge said Thursday that Johnson & Johnson chief executive officer Alex Gorsky can't be called as a witness by a plaintiff... Read more

J&J's Alex Gorsky testify? Much too busy ... on the other side of the planet

Comment icon 0 Comments
People will just have to understand that Johnson & Johnson chief executive officer Alex Gorsky has places to go. He does not have time... Read more

J&J CEO Alex Gorsky talks Risperdal, via deposition, with lawyers nearby

Comment icon 0 Comments
Johnson & Johnson Chief Executive Office Alex Gorsky was proud enough of helping to boost Risperdal sales to include the numbers on his... Read more

Teva sells animal drug unit to Bayer for up to $145 million

Comment icon 0 Comments
Teva Pharmaceuticals, which recently changed leadership and is re-examining what it plans to focus on, said Friday morning that it sold its... Read more